Ranveer Nand

Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors.

C. Bredeson, S. Kroft, E. Atallah, 2009, Leukemia research.

Prospective validation of genetic predictors of aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

A. Benson, J. Sparano, C. Loprinzi, 2021 .